Cibc Private Wealth Group, LLC Teva Pharmaceutical Industries LTD Transaction History

Cibc Private Wealth Group, LLC

$53.9 Billion
Q3 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 4,649 shares of TEVA stock, worth $105,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,649

Previous 4,611 0.82%

Holding current value

$105,160

Previous $74,000 12.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$15.81 - $18.96 $600 - $720	38 Added 0.82%	4,649 $83,000
Q2 2024 Aug 09, 2024	BUY	$12.78 - $17.4 $49,880 - $67,912	3,903 Added 551.27%	4,611 $74,000
Q1 2024 May 10, 2024	BUY	$10.67 - $14.43 $7,554 - $10,216	708 New	708 $9,000
Q3 2019 Oct 16, 2019	SELL	$6.16 - $9.6 $85,254 - $132,864	-13,840 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$8.12 - $15.72 $4,871 - $9,432	-600 Reduced 4.16%	13,840 $128,000
Q1 2019 May 10, 2019	SELL	$15.58 - $20.01 $1.14 Million - $1.46 Million	-73,100 Reduced 83.5%	14,440 $226,000
Q4 2018 Feb 05, 2019	BUY	$14.59 - $23.84 $14,590 - $23,840	1,000 Added 1.16%	87,540 $1.35 Million
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $1.44 Million - $1.76 Million	68,600 Added 382.39%	86,540 $1.86 Million
Q2 2018 Aug 02, 2018	BUY	$16.77 - $24.71 $24,819 - $36,570	1,480 Added 8.99%	17,940 $436,000
Q1 2018 May 17, 2018	BUY	$16.68 - $22.07 $32,676 - $43,235	1,959 Added 13.51%	16,460 $281,000
Q4 2017 Feb 12, 2018	BUY	$11.23 - $19.1 $13,476 - $22,920	1,200 Added 9.02%	14,501 $275,000
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $24,763 - $51,697	1,607 Added 13.74%	13,301 $234,000
Q2 2017 Aug 09, 2017	BUY	N/A	11,694	11,694 $388,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Teva Pharmaceutical Industries LTD Transaction History